moxifloxacin has been researched along with Leprosy, Cutaneous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abalos, RM; Andaya, CE; Burgos, J; Dela Crux, E; Fajardo, TT; Gelber, RH; Pardillo, FE; Paredes, RM | 1 |
1 other study(ies) available for moxifloxacin and Leprosy, Cutaneous
Article | Year |
---|---|
Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy.
Topics: Adult; Aza Compounds; Fluoroquinolones; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Microbial Viability; Middle Aged; Moxifloxacin; Mycobacterium leprae; Quinolines; Skin; Treatment Outcome | 2009 |